1
Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:September 12, 2019Terminated
Neovascularization, Pathologic: 1027 Clinical Trials, Page 1 of 11
Hide Studies Not Open or Pending
2
Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient
Condition(s):Pressure Ulcer; Bedsore; Spinal Cord Injury; ParaplegiaLast Updated:May 18, 2018Recruiting
3
Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions
Condition(s):Corneal Neovascularization; Corneal Graft Failure; Anterior Segment InflammationLast Updated:August 3, 2016Withdrawn
4
The Effect of Bevacizumab on Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:December 1, 2011Completed
5
Strategies for Management of Corneal Neovascularisation
Condition(s):Corneal NeovascularisationLast Updated:December 1, 2015Unknown status
6
Bevacizumab for the Treatment of Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:October 13, 2009Unknown status
7
Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:November 7, 2007Completed
8
68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis
Condition(s):Pathological AngiogenesisLast Updated:November 13, 2016Unknown status
9
Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:July 3, 2013Completed
10
Treatment of Corneal Neovascularization With Topical Pazopanib
Condition(s):Corneal NeovascularizationLast Updated:December 19, 2017Completed
11
“In Vivo” Comparison in Human Carotid Atherosclerosis: Plaque Neovascularization
Condition(s):Carotid Artery Disease; Plaque NeovascularizationLast Updated:November 20, 2017Completed
12
Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization
Condition(s):Myopic Choroidal NeovascularisationLast Updated:July 2, 2019Recruiting
13
Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID).
Condition(s):Choroidal Neovascularization in Angioid StreaksLast Updated:January 5, 2017Withdrawn
14
Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial
Condition(s):Choroidal NeovascularizationLast Updated:September 18, 2012Completed
15
Squalamine for the Treatment in Proliferative Diabetic Retinopathy
Condition(s):Retinal NeovascularizationLast Updated:February 9, 2015Completed
16
Topical Avastin for Treatment of Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:October 2, 2012Completed
17
Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea
Condition(s):Corneal NeovascularizationLast Updated:October 5, 2015Terminated
18
Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia
Condition(s):Choroidal Subfoveal/Juxtafoveal Neovascularization in High MyopiaLast Updated:March 27, 2017Unknown status
19
Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits
Condition(s):Angiogenesis; Ischemic StrokeLast Updated:November 10, 2015Unknown status
20
Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen
Condition(s):Choroidal NeovascularisationLast Updated:April 15, 2016Completed
21
Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Condition(s):Choroidal NeovascularizationLast Updated:December 30, 2015Withdrawn
22
Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization
Condition(s):Choroidal NeovascularizationLast Updated:March 7, 2019Completed
23
Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery
Condition(s):Corneal NeovascularizationLast Updated:July 7, 2017Completed
24
Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
Condition(s):Choroidal Neovascularization; Myopia, DegenerativeLast Updated:October 28, 2011Completed
25
Ranibizumab for Myopic Neovascularization
Condition(s):Myopic Choroidal NeovascularizationLast Updated:December 31, 2013Unknown status
26
Real Life Study in Myopic Neovascularization
Condition(s):Myopic Choroidal NeovascularisationLast Updated:January 7, 2019Recruiting
27
Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization
Condition(s):Choroidal Retinal NeovascularizationLast Updated:January 9, 2014Unknown status
28
Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3)
Condition(s):Type 3 Choroidal NeovascularizationLast Updated:March 7, 2019Completed
29
Bevacizumab Intravitreal for Myopic Choroidal Neovascularization
Condition(s):Myopic Choroidal NeovascularizationLast Updated:November 24, 2008Completed
30
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization
Condition(s):Macular Degeneration; Choroidal NeovascularizationLast Updated:March 23, 2011Completed
31
A Pilot Study for the Treatment of Iris Neovascularization With Macugen
Condition(s):Iris Neovascularization; Diabetic RetinopathyLast Updated:September 3, 2008Completed
32
Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)
Condition(s):Corneal NeovascularizationLast Updated:October 10, 2012Completed
33
Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)
Condition(s):Choroidal NeovascularizationLast Updated:June 14, 2012Completed
34
Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.
Condition(s):Choroidal Neovascularization (CNV)Last Updated:August 15, 2016Completed
35
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
Condition(s):Angioid Streaks; Choroidal NeovascularizationLast Updated:January 23, 2008Unknown status
36
Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease
Condition(s):Retinal IschemiaLast Updated:November 17, 2014Completed
37
Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization
Condition(s):Subfoveal Choroidal NeovascularizationLast Updated:June 29, 2009Unknown status
38
Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor
Condition(s):Choroidal Neovascularization; Punctate Inner ChoroidopathyLast Updated:January 6, 2019Completed
39
Utero-placental Vascularisation in Normal and Preeclamptic and Intra-uterine Growth Restriction Pregnancies
Condition(s):Preeclampsia; Intra-uterine Growth RestrictionLast Updated:July 4, 2016Unknown status
40
Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging
Condition(s):Proliferative Diabetic RetinopathyLast Updated:November 4, 2014Completed
41
A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
Condition(s):Choroidal Neovascularization Secondary to Pathologic MyopiaLast Updated:October 8, 2018Completed
42
Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis
Condition(s):ThrombosisLast Updated:April 21, 2017Terminated
43
Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)
Condition(s):Choroidal Neovascularization; Degenerative Myopia; Pathological MyopiaLast Updated:February 2, 2009Completed
44
Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
Condition(s):Choroidal Neovascularization; Wet Macular DegenerationLast Updated:November 7, 2018Active, not recruiting
45
TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration
Condition(s):Choroidal NeovascularizationLast Updated:February 2, 2006Unknown status
46
SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia
Condition(s):Choroidal Neovascularization; Age Related Macular DegenerationLast Updated:January 30, 2018Completed
47
Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Condition(s):Subfoveal Choroidal Neovascularization (CNV); Secondary to Age-related Macular Degeneration (AMD)Last Updated:March 2, 2016Completed
48
A Study Of Early Markers Of Choroidal Neovascularization
Condition(s):Choroidal Neovascularization (CNV); Age-related Macular Degeneration (AMD); Early MarkersLast Updated:November 9, 2010Terminated
49
Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Condition(s):Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)Last Updated:February 22, 2011Completed
50
Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Condition(s):Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)Last Updated:March 31, 2019Completed
51
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Condition(s):Choroidal Neovascularization; Age-related Macular DegenerationLast Updated:November 28, 2017Completed
52
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
Condition(s):Macular Degeneration; Choroidal NeovascularizationLast Updated:April 18, 2011Terminated
53
Contrast-enhanced Ultrasound (CE-US) and Magnetic Resonance Imaging (MRI): Evaluating Plaque Neovascularisation
Condition(s):Carotid Artery Stenosis; AtherosclerosisLast Updated:April 19, 2011Completed
54
EXTEND III – Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Condition(s):Choroidal Neovascularization; Age-Related Macular DegenerationLast Updated:November 16, 2016Completed
55
Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration
Condition(s):Choroidal Neovascularization; Macular DegenerationLast Updated:March 3, 2008Completed
56
Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.
Condition(s):Choroidal NeovascularizationLast Updated:January 7, 2010Completed
57
Intravitreal Conbercept for Idiopathic Choroidal Neovascularization
Condition(s):Idiopathic Choroidal NeovascularizationLast Updated:August 9, 2016Unknown status
58
Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization
Condition(s):Choroidal NeovascularizationLast Updated:September 18, 2019Completed
59
Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization
Condition(s):Neovascularization; Tuberculosis; Multifocal Serpiginous Choroiditis; Harada ToxoplasmosisLast Updated:March 25, 2008Completed
60
Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Condition(s):Age-Related Macular Degeneration; Choroidal NeovascularizationLast Updated:March 16, 2012Completed
61
Analysis of the Variation of the Retinal Vascularization After a Prolonged Effort
Condition(s):Retinal Vascular Disorder; Sport InjuryLast Updated:May 6, 2019Completed
62
Topical IL-1-Ra for Treatment of Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:May 5, 2017Terminated
63
An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO
Condition(s):Choroidal Neovascularization, Age-related Macular DegenerationLast Updated:April 5, 2017Completed
64
Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Condition(s):Age-Related Macular Degeneration; Neovascularization, ChoroidalLast Updated:May 23, 2017Completed
65
Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease – A Prospective Study
Condition(s):Choroidal NeovascularizationLast Updated:December 12, 2013Unknown status
66
A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Condition(s):Choroidal NeovascularizationLast Updated:September 20, 2019Completed
67
Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA).
Condition(s):Inflammatory Choroidal NeovascularizationLast Updated:October 22, 2018Active, not recruiting
68
Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:March 24, 2015Completed
69
Impact of Nicotine on Retinal Vascularization
Condition(s):TabagismLast Updated:July 18, 2019Recruiting
70
VEGF and PEDF in Patients With Myopic Choroidal Neovascularization
Condition(s):Myopic Choroidal Neovascularization; VEGF Aqueous Level; PEDF Aqueous LevelLast Updated:June 25, 2014Completed
71
Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young Patients
Condition(s):Idiopathic Choroidal NeovascularizationLast Updated:July 22, 2019Completed
72
A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population
Condition(s):Geographic Atrophy; Wet Macular Degeneration; Retinal DrusenLast Updated:August 14, 2012Completed
73
Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration
Condition(s):Choroidal Neovascularization; Retinal Pigment Epithelial DetachmentLast Updated:June 26, 2012Completed
74
Estimation of Vascularization After Treatment of Deep Rectovaginal Endometriosis Node by Rectal Shaving
Condition(s):Deep Endometriosis; Recto Vaginal NodeLast Updated:February 1, 2019Recruiting
75
Contraceptive Pills and Retinal Vascularization
Condition(s):Combined Oral Contraceptives IntakeLast Updated:July 18, 2019Recruiting
76
Choroidal Blood Flow and Progression of Age-Related Macular Degeneration in the Fellow Eye in Patients With Unilateral Choroidal Neovascularisation
Condition(s):Regional Blood FlowLast Updated:December 12, 2008Completed
77
Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD
Condition(s):Choroidal Neovascularization; Macular DegenerationLast Updated:January 25, 2007Completed
78
Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia
Condition(s):Pathologic MyopiaLast Updated:May 23, 2019Recruiting
79
Photodynamic Therapy With Verteporfin for Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:October 16, 2008Completed
80
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
Condition(s):Choroidal NeovascularizationLast Updated:July 9, 2008Completed
81
Neovascularization Patterns in Corneal Graft Rejection
Condition(s):Corneal TransplantLast Updated:March 13, 2017Completed
82
Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization
Condition(s):Age-related Macular DegenerationLast Updated:May 6, 2011Completed
83
Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration
Condition(s):Subfoveal Choroidal Neovascularization; Age-Related MaculopathyLast Updated:August 1, 2012Terminated
84
Serum Biomarker of Plaque Vulnerability and Contrast Ultrasound of Carotid Artery
Condition(s):Intraplaque Neovascularization Evaluated by Carotid Enhanced Ultrasound Well Reflect the Plaque VulnerabilityLast Updated:August 22, 2014Completed
85
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
Condition(s):Retinal Neovascularization; Macular EdemaLast Updated:July 5, 2017Unknown status
86
VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV)
Condition(s):Myopia, PathologicalLast Updated:April 17, 2014Completed
87
Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia
Condition(s):Myopic Choroidal Neovascular MembraneLast Updated:September 1, 2015Withdrawn
88
Mechanisms Regulating Wound Vascularization
Condition(s):Wounds and InjuriesLast Updated:July 20, 2017Unknown status
89
The Influence of Eccentric Training on the Volume and Vascularisation of the Rotator Cuff in Patients With Rotator Cuff Tendinopathy and Healthy Subjects
Condition(s):Rotator Cuff TendinopathyLast Updated:December 4, 2014Unknown status
90
OCT and Microperimetry in Patients With Active Neovascular ARMD (CORFI)
Condition(s):Choroidal Neovascularization, Visual Field, Visual AcuityLast Updated:January 21, 2019Recruiting
91
Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)
Condition(s):Maculopathy, Age-Related; Choroidal NeovascularizationLast Updated:October 2, 2009Completed
92
Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD
Condition(s):Macular Degeneration; Choroidal NeovascularizationLast Updated:March 25, 2010Terminated
93
Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Condition(s):Pathological MyopiaLast Updated:January 14, 2014Completed
94
A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Condition(s):Choroidal Neovascularization; Age-related Macular DegenerationLast Updated:March 6, 2014Completed
95
Proteomics and Stem Cell Therapy as a New Vascularization Strategy
Condition(s):Critical Limb IschemiaLast Updated:June 13, 2016Unknown status
96
Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
Condition(s):Uveitis; Diabetic Retinopathy; Choroidal NeovascularizationLast Updated:July 20, 2011Unknown status
97
Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia
Condition(s):Myopia, DegenerativeLast Updated:October 25, 2013Completed
98
Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus “Treat and Extend” Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)
Condition(s):Age-related Macular DegenerationLast Updated:May 23, 2013Completed
99
Predictive Value of Neovascularization Within Asymptomatic Carotis Stenosis on CEUS
Condition(s):Carotid StenosisLast Updated:November 19, 2018Recruiting
100
Resveratrol for Exudative Age-Related Macular Degeneration
Condition(s):AMD; Age-related Macular Degeneration; Choroidal NeovascularisationLast Updated:May 23, 2016Unknown status